Advertisement

Index by author

May 01, 2014; Volume 349,Issue 2

  1. Maarsingh, H.

    1. Arginase Inhibition Prevents Inflammation and Remodeling in a Guinea Pig Model of Chronic Obstructive Pulmonary Disease
      T. Pera, A. B. Zuidhof, M. Smit, M. H. Menzen, T. Klein, G. Flik, J. Zaagsma, H. Meurs and H. Maarsingh
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 229-238; DOI: https://doi.org/10.1124/jpet.113.210138

  2. Maillet, Isabelle

    1. Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis
      Lutz Wollin, Isabelle Maillet, Valérie Quesniaux, Alexander Holweg and Bernhard Ryffel
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 209-220; DOI: https://doi.org/10.1124/jpet.113.208223

  3. Menzen, M. H.

    1. Arginase Inhibition Prevents Inflammation and Remodeling in a Guinea Pig Model of Chronic Obstructive Pulmonary Disease
      T. Pera, A. B. Zuidhof, M. Smit, M. H. Menzen, T. Klein, G. Flik, J. Zaagsma, H. Meurs and H. Maarsingh
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 229-238; DOI: https://doi.org/10.1124/jpet.113.210138

  4. Meurs, H.

    1. Arginase Inhibition Prevents Inflammation and Remodeling in a Guinea Pig Model of Chronic Obstructive Pulmonary Disease
      T. Pera, A. B. Zuidhof, M. Smit, M. H. Menzen, T. Klein, G. Flik, J. Zaagsma, H. Meurs and H. Maarsingh
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 229-238; DOI: https://doi.org/10.1124/jpet.113.210138

  5. Mifflin, Steve W.

    1. 5-Hydroxytryptamine–Mediated Neurotransmission Modulates Spontaneous and Vagal-Evoked Glutamate Release in the Nucleus of the Solitary Tract Effect of Uptake Blockade
      Patrick S. Hosford, Steve W. Mifflin and Andrew G. Ramage
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 288-296; DOI: https://doi.org/10.1124/jpet.113.211334

  6. Milner, Andrea

    1. Follistatin: A Novel Therapeutic for the Improvement of Muscle Regeneration
      Benjamin C. Yaden, Johnny E. Croy, Yan Wang, Jonathan M. Wilson, Amita Datta-Mannan, Pamela Shetler, Andrea Milner, Henry U. Bryant, Jessica Andrews, Guoli Dai and Venkatesh Krishnan
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 355-371; DOI: https://doi.org/10.1124/jpet.113.211169

  7. Mizuguchi, Hiroshi

    1. Tolvaptan Delays the Onset of End-Stage Renal Disease in a Polycystic Kidney Disease Model by Suppressing Increases in Kidney Volume and Renal Injury
      Miki Aihara, Hiroyuki Fujiki, Hiroshi Mizuguchi, Katsuji Hattori, Koji Ohmoto, Makoto Ishikawa, Keisuke Nagano and Yoshitaka Yamamura
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 258-267; DOI: https://doi.org/10.1124/jpet.114.213256

  8. Morgan, Drake

    1. A Novel Aminotetralin-Type Serotonin (5-HT) 2C Receptor-Specific Agonist and 5-HT2A Competitive Antagonist/5-HT2B Inverse Agonist with Preclinical Efficacy for Psychoses
      Clinton E. Canal, Drake Morgan, Daniel Felsing, Krishnakanth Kondabolu, Neil E. Rowland, Kimberly L. Robertson, Rajeev Sakhuja and Raymond G. Booth
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 310-318; DOI: https://doi.org/10.1124/jpet.113.212373
Back to top

In this issue

Advertisement